Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 897

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 897
---
 including, without limitation, any such policy established to comply with the Dodd-Frank Wall Street Reform and Consumer Protection Act, (ii) applicable law (including, without limitation, Section 304 of the Sarbanes-Oxley Act and Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act), and/or (iii) the rules and regulations of the applicable securities exchange or inter-dealer quotation system on which the Common Shares or other securities are listed or quoted, and such requirements shall be deemed incorporated by reference into all outstanding Award Agreements.

<div align='center'>[Signature page follows]</div>

| G-24 |

IN WITNESS WHEREOF, this Longevity Biomedical, Inc. 2025 Equity Incentive Plan has been duly approved and adopted by the Company and the shareholders as of the dates set forth below.

Adopted by the Board: [ ], 2025

Shareholder Approved [ ], 2025

| LONGEVITY BIOMEDICAL, INC. |        |
| By:                        |        |
|                            | [Name] |
| Title:                     |        |
| Date:                      |        |

<div align='center'>[Signature page to Longevity Biomedical, Inc. 2025 Equity Incentive Plan]</div>

<div align='center'>ADDENDUM A

Longevity Biomedical, INC.

2025 EQUITY INCENTIVE PLAN

CALIFORNIA PARTICIPANTS</div>

Prior to the date, if ever, on which the Common Shares of the Company becomes a listed security and/or the Company is subject to the reporting requirements of the Exchange Act, the terms of this Addendum shall apply to Awards issued to a Participant whose Award is issued in reliance on Section 25102(o) of the California Corporations Code (a “ California Participant”). This Addendum is intended to satisfy the requirements of Section 25102(o) of the California Corporations Code and the regulations issued thereunder (“ Section 25102(o)”). Definitions in the Plan and Award Agreement are applicable to this Addendum.

1.In the event of termination of the Participant’s employment or other service other than for Cause, Options that are exercisable on the date of termination may not terminate prior to the earlier to occur of the Option expiration date or thirty (30) days from termination (six (6) months if termination is due to death or disability).

2.Notwithstanding anything to the contrary in the Plan, no Option Award may be exercisable on or after